pryidostigmine bromide

Generic: pyridostigmine bromide

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pryidostigmine bromide
Generic Name pyridostigmine bromide
Labeler rising pharma holdings, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

pyridostigmine bromide 60 mg/5mL

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-833
Product ID 16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208797
Listing Expiration 2026-12-31
Marketing Start 2022-09-15

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571833
Hyphenated Format 16571-833

Supplemental Identifiers

RxCUI
903843
UPC
0316571833160
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pryidostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number ANDA208797 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE, PLASTIC (16571-833-16)
source: ndc

Packages (1)

Ingredients (1)

pyridostigmine bromide (60 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b46177b2-68dc-4958-a4ec-d4bd6d887456", "openfda": {"upc": ["0316571833160"], "unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["beda905e-005a-439d-ac74-92db4e269780"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE, PLASTIC (16571-833-16)", "package_ndc": "16571-833-16", "marketing_start_date": "20220915"}], "brand_name": "Pryidostigmine Bromide", "product_id": "16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "16571-833", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pryidostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "ANDA208797", "marketing_category": "ANDA", "marketing_start_date": "20220915", "listing_expiration_date": "20261231"}